Enhanced anti-tumor responses induced by the combination of a couple of stimulators: IL-12 and CCL27

被引：0
|
作者：
Sugita, T
Gao, JQ
Kanagawa, N
Motomura, Y
Nakayama, T
Yoshie, O
Hatanaka, Y
Tani, Y
Mizuguchi, H
Tsutsumi, Y
Nakagawa, S
机构：
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan
[2] Kinki Univ, Sch Med, Dept Microbiol, Osaka 589, Japan
[3] DakoCytomat Co Ltd, Dept Biomed Sci, Kyoto, Japan
[4] Natl Inst Biomed Innovat, Osaka, Japan
来源：
JOURNAL OF GENE MEDICINE | 2006年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [31] AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models
    Sutton, David
    Prentiss, Pilar
    Furmanski, Brian
    MOLECULAR THERAPY, 2022, 30 (04) : 161 - 161
  • [32] Intratumoral delivery of aluminum hydroxide-tethered IL-12 induces potent anti-tumor immune response
    Battula, Sailaja
    Papastoitsis, Gregory
    Kaufman, Howard L.
    Irvine, Darrell J.
    Wittrup, K. Dane
    Schmidt, Michael M.
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Membrane-bound p35 Subunit of IL-12 on Tumor Cells is Functionally Equivalent to Membrane-bound Heterodimeric Single Chain IL-12 for Induction of Anti-tumor Immunity
    Kim, Hyun-Jin
    Park, Sang Min
    Lee, Hayyoung
    Kim, Young Sang
    IMMUNE NETWORK, 2016, 16 (05) : 305 - 310
  • [34] Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
    Chi, Xiaowei
    Yang, Peiwei
    Zhang, Erhao
    Gu, Jieyi
    Xu, Hui
    Li, Mengwei
    Gao, Xinmei
    Li, Xin
    Zhang, Yinan
    Xu, Hanmei
    Hu, Jialiang
    CANCER MEDICINE, 2019, 8 (10): : 4753 - 4765
  • [35] Anti-tumor effect of a tumor cell vaccine expressing membrane-bound form of IL-12 subunit p35
    Park, Sang Min
    Do, Seon Ah
    Kim, Young Sang
    CYTOKINE, 2011, 56 (01) : 101 - 101
  • [36] Anti-tumor effects of a tumor cell vaccine expressing a membrane-bound form of the IL-12 p35 subunit
    Lim, Ho Yong
    Ju, Hee Young
    Chung, Hee-Yong
    Kim, Young Sang
    CANCER BIOLOGY & THERAPY, 2010, 10 (04) : 336 - 343
  • [37] Cell therapy with surface-tethered IL-12 improves anti-tumor efficacy and activates the endogenous immune system
    Nardozzi, Jon
    Geretti, Elena
    Chang, De-Kuan
    McMillin, Douglas W.
    Lyons, Jesse
    Nielsen, Ulrik
    Andresen, Thomas
    Jones, Douglas
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70
    Douin-Echinard, V
    Robbins, PD
    Lotze, MT
    Favre, G
    Couderc, B
    GENE THERAPY OF CANCER, 1998, 451 : 353 - 357
  • [39] Establishment of a SCID mouse model for synergistic anti-tumor effect of human IL-12 and B7-1
    Gao, J
    Zhao, P
    Chen, XH
    Li, M
    Long, JQ
    Gu, AM
    Wu, XL
    Cao, GW
    Qi, ZT
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2003, 35 (06) : 529 - 535
  • [40] Intratumor adoptive transfer of IL-12 mRNA transiently engineered anti-tumor CD8+T cells
    Etxeberria, Inaki
    Bolanos, Elixabet
    Teijeira, Alvaro
    Azpilicueta, Arantza
    Ignacio Quetglas, Jose
    Rodriguez Sanchez-Paulete, Alfonso
    Otano, Itziar
    Mancheno, Uxua
    Hervas-Stubbs, Sandra
    Inoges, Susana
    Garasa, Saray
    Alvarez, Maite
    Berraondo, Pedro
    Melero, Ignacio
    CANCER RESEARCH, 2019, 79 (13)
12345